Industry Analysis: Pharma “The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent.”Richard Gerster Presented By:- NeerajGoswami PrernaAgarwal OjaswiKatiyar
Contents 1) Overview of Indian pharma. 2) Evolution of Indian Pharma. 3) Major players. 4) Drug Trial. 5) Medical tourism. 6) Moving up to the value chain. 7) Pharmaceutical-association in India. 8) Future scenario. 9) Pharma in news.
Indian Pharmaceutical Evolution Phase V Innovation and Research
New IP law
Phase IV Growth Phase
Rapid expansion of domestic market
International market development
Phase III Development Phase
Production infrastructure creation
Phase II Government Control
Indian Patent Act –1970
Drug prices capped
Local companies begin to make an impact
Phase I Early Years
Market share domination by foreign companies
Relative absence of organized Indian companies
1970 1980 1990 2000 2010
Drug Trial Phase-1 Phase-2 Phase-3 Phase-4 Benefits:- Play an active role in their own health care. Gain access to new research treatments before they are widely available. Obtain expert medical care at leading health care facilities during the trial. Help others by contributing to medical research. Risks:- There may be unpleasant, serious or even life-threatening side effects to experimental treatment. The experimental treatment may not be effective for the participant.
Medical Tourism Cheaper medical and relaxation needs. Excellent infrastructure and technology in which is in par with those in USA, UK and Europe. Some treatments which are best in India are:- Eye Care Dental Care IVF Treatment Heart Surgery & Heart Care Health Check Up Cosmetic Treatment Orthopedic Surgery
Moving up the Value Chain VALUE Innovative Products Specialty Products Generic exports to developed countries Generic exports to under-developed & developing countries API Exports TIME
Pharmaceutical Associations In India IDMA CIPI-SSI OPPI IPA BDMA APTI
Indian Pharma Industry – Future Scenario The Indian pharma industry is still trying to come to terms with the new patent regime. Over the next 5 years, will continue to grow by at least twice the rate of global growth. Retail segment will be the fastest growing segment. There will be a significant increase in the clinical trials and diagnostics outsourcing. A significant window of opportunity will be available expiring patents.
Pharma in News August 20, 2008: 49 babies die at leading hospitals under drug trail process. Fight between Ranbaxy and Pfizer.(Lipitor) H1N1 vaccination available in Indian Pharmaceutical market. (Nasovac) Aurobindo pharma and Astra-Zeneca to jointly supply solid dosage in emerging market.